5-FLUOROURACIL PLUS HIGH-DOSE LEUCOVORIN FOR THERAPY OF 5-FLUOROURACIL-RESISTANT METASTATIC COLORECTAL-CANCER

被引：0
|
作者：
OSTERWALDER, B [1 ]
SCHMID, L [1 ]
JUNGI, WF [1 ]
SENN, HJ [1 ]
机构：
[1] KANTONSSPITAL,DIV ONCOL,CH-9007 ST GALLEN,SWITZERLAND
来源：
BLUT | 1988年 / 57卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：207 / 207
页数：1
相关论文
共 50 条
  • [1] LACK OF EFFECTIVENESS OF COMBINED 5-FLUOROURACIL AND LEUCOVORIN IN PATIENTS WITH 5-FLUOROURACIL-RESISTANT ADVANCED COLORECTAL-CANCER
    VANGROENINGEN, CJ
    PETERS, GJ
    PINEDO, HM
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (01): : 45 - 49
  • [2] Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen
    André, T
    Louvet, C
    Raymond, E
    Tournigand, C
    de Gramont, A
    [J]. ANNALS OF ONCOLOGY, 1998, 9 (11) : 1251 - 1253
  • [3] EFFECT OF CISPLATIN IN ADVANCED COLORECTAL-CANCER RESISTANT TO 5-FLUOROURACIL PLUS (S)-LEUCOVORIN
    CASSANO, A
    POZZO, C
    CORSI, CD
    FONTANA, T
    NOVIELLO, MR
    ASTONE, A
    BARONE, C
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1995, 121 (08) : 474 - 477
  • [4] HIGH-DOSE LEUCOVORIN (CF), 5-FLUOROURACIL (5-FU) AND CISPLATIN (CIS) CHEMOTHERAPY IN PATIENTS WITH METASTATIC COLORECTAL-CANCER
    SCHEITHAUER, W
    DEPISCH, D
    SCHIESSEL, R
    ZIELINSKI, C
    PREIS, P
    GISSLINGER, H
    LUDWIG, H
    [J]. BLUT, 1988, 57 (04): : 206 - 206
  • [5] WEEKLY HIGH-DOSE INFUSION OF 5-FLUOROURACIL IN ADVANCED COLORECTAL-CANCER
    DIAZRUBIO, E
    ARANDA, E
    MARTIN, M
    GONZALEZMANCHA, R
    GONZALEZLARRIBA, J
    BARNETO, I
    [J]. EUROPEAN JOURNAL OF CANCER, 1990, 26 (06) : 727 - 729
  • [6] HIGH-DOSE FOLINIC ACID AND 5-FLUOROURACIL IN ADVANCED COLORECTAL-CANCER
    DICOSTANZO, F
    BARTOLUCCI, R
    PADALINO, D
    BRUGIA, M
    BUZZI, F
    [J]. CANCER INVESTIGATION, 1988, 6 (02) : 133 - 138
  • [7] 5-FLUOROURACIL AND LOW-DOSE LEUCOVORIN IN METASTATIC COLORECTAL-CANCER - A PILOT-STUDY
    FRIED, G
    TSALIK, M
    STEIN, M
    DALE, J
    HAIM, N
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1995, 35 (05) : 437 - 440
  • [8] METASTATIC OR LOCALLY ADVANCED COLORECTAL-CANCER TREATED WITH 5-FLUOROURACIL AND LOW-DOSE LEUCOVORIN
    ANDERSEN, LJ
    BRUNSGAARD, NH
    MEJLHOLM, I
    JENSEN, BB
    [J]. ACTA ONCOLOGICA, 1994, 33 (08) : 931 - 934
  • [9] Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer
    M Moehler
    A Eimermacher
    J Siebler
    T Höhler
    A Wein
    M Menges
    D Flieger
    T Junginger
    T Geer
    E Gracien
    P R Galle
    M Heike
    [J]. British Journal of Cancer, 2005, 92 : 2122 - 2128
  • [10] Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer
    Moehler, M
    Eimermacher, A
    Siebler, J
    Höhler, T
    Wein, A
    Menges, M
    Flieger, D
    Junginger, T
    Geer, T
    Gracien, E
    Galle, PR
    Heike, M
    [J]. BRITISH JOURNAL OF CANCER, 2005, 92 (12) : 2122 - 2128
12345